Bukwang Pharm: “Spinning Off Danish Subsidiary and Strengthening Momentum for RNA Therapeutics Development”
Bukwang Pharm announced on the 18th that its Danish subsidiary Contera Pharma will spin off its RNA therapeutics…
Bukwang
2 개의 기사가 있습니다.
Bukwang's Performance Declines Over 2.5 Years Under OCI: Will Q3 Bring a Turnaround?
It's been two and a half years since OCI became the largest shareholder of Bukwang Pharmaceutical, yet instead…